Isomorphic Labs raises $5B to accelerate AI-first drug design, says Demis Hassabis
demishassabis · x · 2026-11-17
Demis Hassabis announced $5B in new funding for Isomorphic Labs to accelerate its mission to "solve all disease." The company aims to reimagine drug design from first principles with AI, radically cutting the time and cost of discovering new medicines. Hassabis describes progress as "gradually, then all at once."
Related event: Isomorphic Labs Raises $5B to Solve All Disease with AI(7 posts)→
More from Venture
- Seedance 2.5 API launching at $0.06 per second of video — eptwts · 2026-11-17
- Apple-Samsung DRAM deal sets minimum supply volume but leaves pricing open to market — zephyr_z9 · 2026-11-17
- Grok Bot Content System: Automate Research, Never Judgment — a $10K Side-Biz Play — PrajwalTomar_ · 2026-11-17
- Solo dev open-sources OpsBridge, an agent workbench for investigating blocked invoices — Fit_Fortune953 · 2026-11-17
- Anthropic's funding roadshow reportedly features just a countdown clock, no slides — morqon · 2026-11-17
- California sues OpenAI over agent incidents; Li Yanhong says AI value lies in apps — 快鲤鱼 · 2026-11-17